Global Endoscopic Ultrasound Needles Market to Reach USD 0.58 Billion by 2036, Driven by Rising Demand for Minimally Invasive Diagnostic Procedures

The global Endoscopic Ultrasound (EUS) Needles Market (https://www.transparencymarketresearch.com/endoscopic-ultrasound-needles-market.html) was valued at USD 0.26 Billion in 2025 and is projected to reach USD 0.58 Billion by 2036, expanding at a CAGR of 8.3% from 2026 to 2036. Market growth is being fueled by the increasing prevalence of gastrointestinal cancers, pancreatic disorders, liver diseases, and other conditions requiring accurate tissue diagnosis through minimally invasive procedures. Continuous advancements in biopsy needle technology, expanding healthcare infrastructure, and increasing adoption of endoscopic ultrasound-guided interventions are further supporting market expansion.

→Discover Market Opportunities - Request Your Sample Copy Now: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=36161

Endoscopic Ultrasound Needles Market Size & Highlights

The Endoscopic Ultrasound Needles Market reached USD 0.26 Billion in 2025 and is expected to attain USD 0.58 Billion by 2036. The market is projected to expand at a CAGR of 8.3% during the forecast period.

North America dominated the global market in 2025, accounting for approximately 40% of total revenue owing to its advanced healthcare infrastructure, high adoption of endoscopic procedures, and increasing incidence of gastrointestinal cancers.

By product type, Fine Needle Aspiration (FNA) Needles (EUS-FNA) accounted for the largest market share of nearly 61% in 2025 due to their widespread use in pancreatic, gastrointestinal, biliary, and mediastinal tissue sampling procedures.

Major companies operating in the market include Olympus Corporation, Medtronic plc, Cook Medical LLC, Boston Scientific Corporation, CONMED Corporation, Medi-Globe GmbH, Micro-Tech Endoscopy, STERIS plc, ENDO-FLEX GmbH, and MTW Endoskopie Manufaktur W. Haag KG.

Analysts' Viewpoint on the Global Endoscopic Ultrasound Needles Market

The Endoscopic Ultrasound Needles Market is witnessing sustained growth due to the increasing burden of gastrointestinal cancers, pancreatic diseases, liver disorders, biliary tract diseases, and other conditions that require highly accurate tissue diagnosis. Healthcare providers are increasingly adopting EUS-guided biopsy procedures because they enable precise sampling of deep-seated lesions while minimizing patient discomfort and procedural complications.

Endoscopic ultrasound has become an indispensable diagnostic and staging tool in gastroenterology and oncology. The combination of high-resolution ultrasound imaging with minimally invasive tissue acquisition enables clinicians to diagnose malignant and benign lesions with exceptional accuracy.

Medical device manufacturers continue to invest heavily in research and development to introduce next-generation Fine Needle Aspiration (FNA) and Fine Needle Biopsy (FNB) devices offering improved flexibility, superior tissue acquisition, enhanced echogenicity, and easier maneuverability during complex procedures.

The expansion of specialized endoscopy centers, increasing investment in advanced diagnostic infrastructure, and growing physician preference for minimally invasive interventions are expected to create favorable growth opportunities throughout the forecast period.

Endoscopic Ultrasound Needles Market Introduction

Endoscopic Ultrasound (EUS) needles are specialized medical devices designed to perform tissue sampling, fine needle aspiration, biopsy, fluid aspiration, and therapeutic interventions under endoscopic ultrasound guidance.

These needles allow physicians to safely access internal organs and difficult-to-reach lesions within or adjacent to the gastrointestinal tract, including the pancreas, liver, lymph nodes, bile ducts, mediastinum, and submucosal tumors.

EUS-guided procedures have become the preferred diagnostic approach for numerous gastrointestinal disorders because they provide high diagnostic accuracy while avoiding invasive surgical biopsies. The technology enables clinicians to obtain cytological and histological samples necessary for disease diagnosis, staging, molecular testing, biomarker analysis, and treatment planning.

Growing awareness regarding early cancer diagnosis, technological advancements in endoscopic imaging systems, and increasing utilization of minimally invasive procedures continue to strengthen the global demand for EUS needles.

Rising Need for Accurate Diagnosis of Pancreatic and Gastrointestinal Diseases Driving Market Growth

The increasing demand for precise diagnosis of pancreatic, gastrointestinal, biliary, and mediastinal diseases has become one of the major factors driving the Endoscopic Ultrasound Needles Market.

EUS-guided Fine Needle Aspiration (FNA) and Fine Needle Biopsy (FNB) procedures enable physicians to obtain high-quality tissue and fluid samples from lesions that are inaccessible through conventional biopsy techniques. These procedures play a critical role in diagnosing pancreatic tumors, gastrointestinal stromal tumors, enlarged lymph nodes, bile duct abnormalities, and various other complex conditions.

The growing incidence of gastrointestinal cancers and pancreatitis has increased the clinical importance of obtaining high-quality tissue specimens for cytological, histopathological, molecular, and biomarker analysis. Early and accurate diagnosis allows clinicians to initiate personalized treatment strategies while improving patient outcomes.

Continuous product innovation has resulted in biopsy needles offering superior tissue capture capabilities, improved flexibility, enhanced echogenicity, and compatibility with modern echoendoscope platforms. As hospitals continue expanding advanced endoscopy services, demand for high-performance EUS biopsy needles is expected to increase significantly.

Growing Preference for Minimally Invasive Tissue Sampling Procedures Accelerating Market Expansion

The increasing preference for minimally invasive diagnostic procedures is another major factor supporting market growth.

Compared with conventional surgical biopsy techniques, EUS-guided tissue sampling provides numerous clinical advantages, including lower patient discomfort, reduced procedural risks, shorter hospital stays, faster recovery, and improved diagnostic accuracy.

Using real-time ultrasound guidance, physicians can precisely access deep anatomical structures while minimizing damage to surrounding tissues. This capability makes EUS-guided biopsy particularly valuable for diagnosing pancreatic lesions, gastrointestinal tumors, liver abnormalities, and mediastinal lymph nodes.

Continuous regulatory approvals and technological innovations have further accelerated the adoption of image-guided biopsy procedures. New-generation biopsy needles incorporate enhanced needle tip geometry, improved stylet control, superior flexibility, and optimized tissue acquisition technologies that increase procedural success while reducing repeat biopsies.

Healthcare providers continue investing in advanced endoscopy suites, imaging systems, biopsy devices, and physician training programs to improve diagnostic capabilities while maintaining patient comfort. These trends are expected to support sustained demand for endoscopic ultrasound needles throughout the forecast period.

Market Opportunity: Expansion of EUS-Guided Biopsy in Precision Oncology

The increasing adoption of precision oncology presents substantial growth opportunities for the Endoscopic Ultrasound Needles Market.

Modern cancer management increasingly relies on molecular profiling, biomarker analysis, and genomic testing to guide individualized treatment decisions. High-quality tissue specimens obtained through EUS-guided biopsy procedures provide the biological material necessary for comprehensive pathological evaluation and precision medicine applications.

EUS-guided Fine Needle Aspiration and Fine Needle Biopsy procedures are extensively utilized for diagnosing and staging pancreatic cancer, gastrointestinal malignancies, bile duct cancers, mediastinal tumors, and metastatic lymph node involvement.

Continuous technological advancements and regulatory approvals have strengthened physician confidence in EUS-guided biopsy devices. Modern biopsy needles are capable of obtaining larger, higher-quality tissue samples suitable for advanced molecular diagnostics while minimizing the need for repeat procedures.

As precision oncology becomes an integral component of cancer care worldwide, healthcare providers are expected to increase adoption of advanced biopsy technologies capable of supporting comprehensive genomic and molecular analysis.

Manufacturers that continue developing biopsy needles with superior tissue acquisition performance, enhanced echogenicity, improved flexibility, and broad compatibility with existing endoscopic platforms are expected to strengthen their competitive positions.

→Explore Strategies & Trends - Request Full Report Access - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=36161

Fine Needle Aspiration (FNA) Needles Lead the Market

Fine Needle Aspiration (FNA) Needles represent the largest product segment within the Endoscopic Ultrasound Needles Market, accounting for approximately 61% of total market revenue.

Their widespread adoption is primarily attributed to extensive utilization in diagnosing pancreatic cancer, gastrointestinal tumors, biliary diseases, mediastinal lesions, and enlarged lymph nodes.

FNA needles enable physicians to obtain cellular samples from difficult-to-access lesions through minimally invasive procedures guided by real-time ultrasound imaging. Their proven diagnostic reliability, procedural efficiency, and broad clinical acceptance have established them as the preferred choice among gastroenterologists and endoscopists worldwide.

Continuous product improvements have enhanced needle flexibility, penetration capability, echogenic visibility, and overall maneuverability during complex procedures. Manufacturers are increasingly focusing on next-generation needle designs that facilitate easier navigation while maximizing tissue acquisition quality.

Growing investments in gastrointestinal cancer screening programs, early diagnosis initiatives, and advanced endoscopy services are expected to further strengthen demand for EUS-FNA needles throughout the forecast period.

Regional Outlook of Endoscopic Ultrasound Needles Market

North America remains the largest regional market for Endoscopic Ultrasound Needles, accounting for approximately 40% of global revenue.

The region's leadership is supported by a high prevalence of pancreatic cancer, gastrointestinal malignancies, liver diseases, and other disorders requiring advanced diagnostic procedures. The United States and Canada possess highly developed healthcare systems equipped with specialized endoscopy centers, experienced gastroenterologists, and state-of-the-art diagnostic infrastructure.

Extensive adoption of EUS-guided Fine Needle Aspiration and Fine Needle Biopsy procedures has significantly contributed to regional market growth. Hospitals continue investing in advanced echoendoscope systems, imaging technologies, and high-performance biopsy devices to improve diagnostic accuracy and patient outcomes.

Supportive reimbursement policies, favorable regulatory frameworks, and continuous clinical research further enhance the region's market position. Major medical device manufacturers are actively introducing innovative biopsy needles with improved tissue acquisition capabilities, enhanced flexibility, and superior echogenic performance.

Although North America dominates the market, Europe continues to witness steady growth through increasing adoption of minimally invasive diagnostic procedures and expanding cancer screening programs. Asia Pacific is expected to emerge as the fastest-growing regional market due to improving healthcare infrastructure, rising healthcare expenditure, growing awareness regarding early cancer diagnosis, and increasing access to advanced endoscopic technologies.

Analysis of Key Players in the Endoscopic Ultrasound Needles Market

The competitive landscape is characterized by continuous technological innovation, product development, regulatory approvals, strategic collaborations, and expansion of global distribution networks.

Leading manufacturers are focusing on developing advanced EUS-guided Fine Needle Aspiration and Fine Needle Biopsy devices that deliver superior tissue acquisition, enhanced flexibility, improved echogenicity, greater procedural accuracy, and compatibility with modern echoendoscope systems.

Increasing demand for biopsy procedures in oncology, gastroenterology, hepatology, and precision medicine continues to encourage investments in research and development.

Major companies operating in the market include Olympus Corporation, Medtronic plc, Cook Medical LLC, Boston Scientific Corporation, CONMED Corporation, Medi-Globe GmbH, Micro-Tech Endoscopy, STERIS plc, ENDO-FLEX GmbH, and MTW Endoskopie Manufaktur W. Haag KG.

These companies continue strengthening their market presence through product innovation, strategic partnerships, regulatory approvals, and expansion into emerging healthcare markets.

Market Segmentation

The Endoscopic Ultrasound Needles Market is segmented by product type into Fine Needle Aspiration (FNA) Needles and Fine Needle Biopsy (FNB) Needles.

Based on application, the market is categorized into bronchial and enteral procedures.

By end-user, the market includes hospitals, specialty clinics, and ambulatory surgery centers.

Geographically, the market covers North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

Future Outlook

The Endoscopic Ultrasound Needles Market is expected to experience robust growth over the coming decade as healthcare systems increasingly prioritize minimally invasive diagnostics, precision oncology, and early disease detection.

Technological advancements in biopsy needle design, ultrasound imaging systems, tissue acquisition methods, and endoscopic platforms will continue improving procedural accuracy and patient outcomes. The growing incidence of gastrointestinal cancers, pancreatic diseases, liver disorders, and other complex conditions requiring precise tissue diagnosis will further support market expansion.

Increasing investments in specialized endoscopy centers, physician training, healthcare infrastructure, and advanced diagnostic technologies are expected to accelerate adoption across both developed and emerging markets.

As personalized medicine, molecular diagnostics, and targeted cancer therapies become increasingly integrated into routine clinical practice, endoscopic ultrasound-guided biopsy procedures will continue playing a critical role in disease diagnosis, staging, biomarker analysis, and treatment planning, ensuring sustained long-term growth for the global Endoscopic Ultrasound Needles Market.

Buy Full Report Now: https://www.transparencymarketresearch.com/checkout.php?rep_id=36161<ype=S

→Explore Latest Research Reports by Transparency Market Research:

Dry Eye Disease Market: https://www.transparencymarketresearch.com/dry-eye-disease-market.html

Inflation Devices Market: https://www.transparencymarketresearch.com/inflation-devices-market.html

Organoids Market: https://www.transparencymarketresearch.com/organoids-market.html

Media Contact:
Abhishek Budholiya
Transparency Market Research Inc.
State Tower, 90 State Street, Suite 700,
Albany NY - 12207, United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Sales Inquiries: sales@transparencymarketresearch.com
Media Inquiries: media@transparencymarketresearch.com

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

This release was published on openPR.